booksshare.net -> -> -> .. -> " " -> 238

- ..

.. , 1962. 711 c.
( ): pharmazeutischewirkstoffe1982.djvu
<< 1 .. 232 233 234 235 236 237 < 238 > 239 240 241 242 243 244 .. 345 >>

Secbutabarbital
USP 1 856 792 (Eli Lilly; ert. 1932; Prior. 1929).
D: DormilEo®CWachter)-Komb. F: Soneryl® (Specia)
Resedorm® (Lappe)-Komb. USA: Butabarbital Sodium (Parke-Davis) mit Aprobarbital Butisol Sodium® (McNeil)
Secobarbital 76-73-3 Hypnoticum
309-43-3 Na-Salz
5-allyl-5-(l-methylbutyl)barbituric acid
H7C3-CH-OH
1
CH3
2-Pentancl
H7C3-
CH-I
I
CH3
2-Pentylbromid
COOC2H5 HjC /NaOC2Hs COOC2H5_
Malonsaure-
diethyiester
(Na-Salz)
COOC2HS
H7C3-CH-CH
I I
CH3 COOC2H5
[1-Methylbutyl}-maion-saure diethylester |(2-Pentyl)-malonsaure-diethylester]
0 H
HjN“C—NHj/NaOC2M5 К0И/Н2С = СН-СН2-6г
Harnstoff ** Allylbromid
H7C3-CH g CH3
5-{!-Methylbutyi)-barbitursaure [5-{2-Pentyl|-barbitursaure ]
H
Н2С=СН-СН2~^^^МН
H7C3-CH у
сн3
Secobarbital
Secobarbital - Secnidazol - Secretin S 817
USP 1 954 429 (Eli Lilly; ert. 1934; CDN-Prior. 1930).
D: Dormilfo® (Wachter)-Komb. Tempidorm® (Roland)-Komb. Trisomin® (Asche)-Komb.
F: Dinoctin (Spret-Mauchant)-Komb. Divinoctal® (I.S.H.)-Komb. Imm^noctal® (I.S.H.) Komb.-Praparate
GB: Seconal Sodium® (Lilly)
I: Immenox® (Roussel Maestretti)
J: Ional Sodium® (Yoshitomi)
USA: Hyptran® (Wallace)-Komb.
Secobarbital Sodium (Parke-Davis; Wyeth) Seconal® (Lilly)
Seconal® Sodium (Lilly)
Secnidazol
3366-95-8
Chemotherapeuticum;
Amoebicid
a,2-dimethyl-5-nitroimidazole-l-ethanol
O'
'-N
CH3
2-Methyl-
imidazol
02N
CH3
2-Methyl-5-
mtroimidazol
/л /нсоон
НзС _
Propylenoxid/
Ameisensaure
; 02N.
ch2-
xN,
OH
I
-СН-СНз 1
-O'"*
GT3
2-Methyl-
imidazol
CI-CH2-C-CH3
Chloraceton
K2C33 /Aceton
О II
CH2-C-CH3
iVcH3
(2-Methyl-1-lmidazolylj-aceton
1 HNO: / PjOs
2 NaBHt/СН3ОН
2 Natriumoorhydnd
DOF 4,280 (1979).
a C. Cosar et al., Arzneim. Forsch. 16, 23 (1966).
FP-M 3270 (Rhone-Poulenc; Anm. 30.12.1963).
FP 1427627 (Rhone-Poulenc; Anm. 10.10.1963). b DOS 2 107 423 (Rhone-Poulenc; Anm. 16.2.1971; F-Prior. 16.2.1970).
GB-P 1278 758 (Rhone-Poulenc; Laufzeit ab 19.4.1971; F-Prior. 16.2.1970). GB-P 1265 466 (Rofine-Poulenc; Laufzeit ab 15.7.1970; F-Prior. 16.2.1970). Weitere Verfahren:
DOS 2 107 405 (Rhone-Poulenc; Anm. 16.2.1971; F-Prior. 16.2.1970).
GB-P 1278 757 (Rhone-Poulenc; Laufzeit ab 19.4.1971; F-Prior. 16.2.1970).
F: Flagentyl® (Rhone-Poulenc)
Secretin 1393-25-5 Diagnosticum
* secretin
| H—L-His—L-Ser— L-Asp-Gly-L-Thr-L-Phe-L-Thr-i.-Ser-1-Glu-l—Leu-L-Ser-l-Arg-L-Leu-L- Arg-L-Asp-L-Ser-L-
!
I Ala-l-Arg-L-LeL-L-Gln-L- Arg-L-leu -L-Leu-l-Gln-G!y-L-Leu-L-Vat—NH2
Secretin
818 S Secretin - Silymarin
Aus Schweineduodenummucosa DOT 16,87 (1980).
J. E. Jorpes, V. Mutt; Acta Chem. Scand. 15,1790 (1961).
Syn these:
USP 3 767 639 (Squibb; ert. 23.10.1973; Prior. 12.4.1968,17.4.1970).
M. Bodanszky et al., J. Am. Chem. Soc. 89,685; 6753 (1967).
M. A. Ondetti et al., J. Am. Chem. Soc. 90,4711 (1968).
E. Wuensch et al., Chem. Ber. 104, 2430,2445, 3854 (1971); 105,2508 (1972). Reinigung:
E. Wuensch et al., Chem. Ber. 105,2515 (1972).
Struktur:
V. Mutt, J. E. Jorpes; Eur. J. Biochem. 15,513 (1970).
F: Secretine Sinbio® (Fimex) J: Secrepan® (Eisai)
GB: Secretin (Boots)
Silymarin 27359-03-1 Lebertherapeuticum
(Silybin)
4H- l-benzopyran-4-one, 2-(2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-l,4-
benzodioxin-6-yl)-2,3-dihydro-3,5,7-trihydroxy-
Durch Extraktion der Frtichte von Silybum mariatium Gaertn. (Mariendistel) und saulenchromatographi-sche Reinigung.
DOT7,216 (1971).
H. Wagner et al., Arzneim.-Forsch. 18,688 (1968); 24, 466 (1974).
DOS 1 767 666 (Madaus Anm. 1.6.1968). Med. Anw.
DAS 1923 082 (Madaus; Anm. 6.5.1969), Isolierung.
Derivate bzw. Salze:
DBP 1 963 318 (ATO Investment; Am. 17.12.1969).
DAS 2 302 593 (Madaus; Anm. 19.1.1973).
D: Dura Silymarin (Durachemie) F: Legalon® (Roger Bellon)
Hepadestal® (Krugmann) I: Legalon® (Ibi)
Legalon® (Madaus) Silliver® (Abbott)
Simfibrat - Sisomicin S 819
Simfibrat 14929-11-4 Antiarterioskleroticum
(Hypolipaemicum)
2-(/?-chlorophenoxy)-2-methvlpropionic acid trimethylene ester CH3
ff \ I I р-TosOH I Cl—((_/—0“ С—COOH + HO-CH2-CH2-CH2-OH J-!-*•.
CH3
2-(4-Chlorphenoxy)~iso- 1,3-Propandtol
buttersaure
(s. S. 227)
Ч3С 0 0 CH3
- - " " ct
:i-i^^>-o-c-c-o-ch2-ch2-ch2-o-c-c-o-<^>-'
H3C CH3
Simfibrat
USP 3494957 (Yoshitomi; ert. 10.2.1970; J-Prior. 5.1.1965).
J: Cholesorbin® (Takeda) I: Qiolesolvin® (Cyanamid)
Sisomicin 32385-11 -8 Antibioticum
53179-09-2 21/г Sulfat
0-2,6-diamino-2,3,4,6-tetradeoxy-a-D-glycero-hex-4-enopyranosyl-(l—»4)-0-[3-deoxy-4-C-methyl-3-(methylamino)-/?-L-arabinopyranosyl-(l^>6)]-2-deoxy-D-streptamine
Aus Fermentationslosungen von Micromonspora inyoesis (NRRL 3292).
DOT 12,407(1976).
DOS 1932 309 (Scherico; Anm. 26.6.1969; USA-Prior. 27.6.1968, 16.12.1968).
USP 3 832 286 (Schering Corp.; ert. 27.8.1974; Prior. 16.12.1968, 27.6.1968, 26.6.1973). USP 3 907 771 (Schering Corp.; ert. 23.9.1975; Prior. 3.2.1971, 16.12.1968,27.6.1968). USP 4009 328 (Scherico; ert. 22.2.1977; Prior. 2.5.1975).
<< 1 .. 232 233 234 235 236 237 < 238 > 239 240 241 242 243 244 .. 345 >>

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed

, ?
2009 BooksShare.
.
Rambler's Top100

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed